Kirkland & Ellis represents Mazor Robotics (NASDAQ: MZOR, TASE: MZOR.TA), a pioneer in the field of robotic guidance systems, which today announced its definitive merger agreement with Medtronic plc (NYSE: MDT), a global leader in medical technology. Under the agreement, Medtronic will acquire all outstanding ordinary shares of Mazor for a total of approximately $1.64 billion. The acquisition is expected to close during Medtronic’s third fiscal quarter ending Jan. 25, 2019, subject to the satisfaction of customary closing conditions including receipt of regulatory clearances and approval by Mazor’s shareholders. More information on the transaction is available in Medtronic and Mazor’s press release.
The Kirkland team includes corporate partners Daniel Wolf and Dvir Oren, and associates Serena Shi and Gilad Zohari.